Role of presynaptic nicotinic acetylcholine receptors in the regulation of gastrointestinal motility

Brain Research Bulletin

Volumn 72, Issue 4-6, 2007, Pages 194-200

  Mandl, P ^a   Kiss, J P ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Enteric nervous system; Gastrointestinal motility; Myenteric motoneuron; Positive feedback; Presynaptic nicotinic acetylcholine receptor

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; IMIPRAMINE; MONOAMINE; NEFAZODONE; NICOTINIC RECEPTOR; PAROXETINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

CHOLINERGIC TRANSMISSION; CONSTIPATION; DENDRITE; GASTROINTESTINAL MOTILITY; HUMAN; INTESTINE INNERVATION; MOTONEURON; MYENTERIC PLEXUS; NERVE CELL; NEUROCHEMISTRY; NONHUMAN; POSITIVE FEEDBACK; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; SOMATIC CELL;

ANIMALS; GASTROINTESTINAL MOTILITY; MODELS, BIOLOGICAL; PRESYNAPTIC TERMINALS; RECEPTORS, NICOTINIC;

EID: 34247157694     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2007.02.005     Document Type: Review

References (99)

1. Araujo D.M., Lapchak P.A., Collier B., and Quirion R. Characterization of N-[3H]methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain. J. Neurochem. 51 (1988) 292-299
2. Arqueros L., Naquira D., and Zunino E. Nicotine-induced release of catecholamines from rat hippocampus and striatum. Biochem. Pharmacol. 27 (1978) 2667-2674
3. Arrang J.M., Garbarg M., Lancelot J.C., Lecomte J.M., Pollard H., Robba M., Schunack W., and Schwartz J.C. Highly potent and selective ligands for histamine H3-receptors. Nature 327 (1987) 117-123
4. Baude A., Nusser Z., Roberts J.D., Mulvihill E., McIlhinney R.A., and Somogyi P. The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron 11 (1993) 771-787
5. Beasley Jr. C.M., Holman S.L., and Potvin J.H. Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial. Ann Clin. Psychiatry 5 (1993) 199-207
6. Beasley Jr. C.M., Koke S.C., Nilsson M.E., and Gonzales J.S. Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis. Clin. Ther. 22 (2000) 1319-1330
7. Bolo N.R., Hode Y., Nedelec J.F., Laine E., Wagner G., and Macher J.P. Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology 23 (2000) 428-438
8. Bonhaus D.W., Bley K.R., Broka C.A., Fontana D.J., Leung E., Lewis R., Shieh A., and Wong E.H. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine. J. Pharmacol. Exp. Ther. 272 (1995) 1199-1203
9. Bowman W.C., Marshall I.G., Gibb A.J., and Harborne A.J. Feedback control of transmitter release at the neuromuscular junction. Trends Pharmacol. Sci. 9 (1988) 16-20
10. Calabrese J.R., Londborg P.D., Shelton M.D., and Thase M.E. Citalopram treatment of fluoxetine-intolerant depressed patients. J. Clin. Psychiatry 64 (2003) 562-567
11. Chesselet M.F. Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis. Neuroscience 12 (1984) 347-375
12. Cohen B.N., Figl A., Quick M.W., Labarca C., Davidson N., and Lester H.A. Regions of beta 2 and beta 4 responsible for differences between the steady state dose-response relationships of the alpha 3 beta 2 and alpha 3 beta 4 neuronal nicotinic receptors. J. Gen. Physiol. 105 (1995) 745-764
13. Corringer P.J., Bertrand S., Bohler S., Edelstein S.J., Changeux J.P., and Bertrand D. Critical elements determining diversity in agonist binding and desensitization of neuronal nicotinic acetylcholine receptors. J. Neurosci. 18 (1998) 648-657
14. Coulie B., Camilleri M., Bharucha A.E., Sandborn W.J., and Burton D. Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects. Aliment Pharmacol. Ther. 15 (2001) 653-663
15. DeVane C.L. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell. Mol. Neurobiol. 19 (1999) 443-466
16. Dolezal V., Schobert A., and Hertting G. Differences of the electrical and nicotinic receptor stimulation-evoked liberation of norepinephrine from chicken sympathetic neurons in culture: possible involvement of different pools of the transmitter. Neurochem. Res. 20 (1995) 261-267
17. Dubocovich M.L., and Langer S.Z. Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxybenzamine in blocking the pre- and post-synaptic adrenergic receptors. J. Physiol. 237 (1974) 505-519
18. Ehlert F.J., Sawyer G.W., and Esqueda E.E. Contractile role of M2 and M3 muscarinic receptors in gastrointestinal smooth muscle. Life Sci. 64 (1999) 387-394
19. Enero M.A., Langer S.Z., Rothlin R.P., and Stefano F.J. Role of the alpha-adrenoceptor in regulating noradrenaline overflow by nerve stimulation. 1971. Br. J. Pharmacol. 120 (1997) 361-377 discussion: 358-360
20. Farnebo L.O., and Hamberger B. Effects of desipramine, phentolamine and phenoxybenzamine on the release of noradrenaline from isolated tissues. J. Pharm. Pharmacol. 22 (1970) 855-857
21. Fenster C.P., Rains M.F., Noerager B., Quick M.W., and Lester R.A. Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J. Neurosci. 17 (1997) 5747-5759
22. Fryer J.D., and Lukas R.J. Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function. J. Neurochem. 72 (1999) 1117-1124
23. Galligan J.J. Nerve terminal nicotinic cholinergic receptors on excitatory motoneurons in the myenteric plexus of guinea pig intestine. J. Pharmacol. Exp. Ther. 291 (1999) 92-98
24. Galligan J.J. Pharmacology of synaptic transmission in the enteric nervous system. Curr. Opin. Pharmacol. 2 (2002) 623-629
25. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., and Lindstrom J. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48 (1995) 774-782
26. Green J.T., McKirdy H.C., Rhodes J., Thomas G.A., and Evans B.K. Intra-luminal nicotine reduces smooth muscle tone and contractile activity in the distal large bowel. Eur. J. Gastroenterol. Hepatol. 11 (1999) 1299-1304
27. Haggblad J., and Heilbronn E. Release of acetylcholine at the motor endplate of the rat-evidence against a muscarinic acetylcholine autoreceptor. Br. J. Pharmacol. 80 (1983) 471-476
28. Hajek P., Gillison F., and McRobbie H. Stopping smoking can cause constipation. Addiction 98 (2003) 1563-1567
29. Hennings E.C., Kiss J.P., De Oliveira K., Toth P.T., and Vizi E.S. Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices. J. Neurochem. 73 (1999) 1043-1050
30. Hennings E.C., Kiss J.P., and Vizi E.S. Nicotinic acetylcholine receptor antagonist effect of fluoxetine in rat hippocampal slices. Brain Res. 759 (1997) 292-294
31. Izaguirre V., Fernandez-Fernandez J.M., Cena V., and Gonzalez-Garcia C. Tricyclic antidepressants block cholinergic nicotinic receptors and ATP secretion in bovine chromaffin cells. FEBS Lett. 418 (1997) 39-42
32. Kalsner S. Presynaptic receptors and autonomic effectors. Ann. NY Acad. Sci. 604 (1990) 23-39
33. Kirchgessner A.L., and Liu M.T. Immunohistochemical localization of nicotinic acetylcholine receptors in the guinea pig bowel and pancreas. J. Comp. Neurol. 390 (1998) 497-514
34. Kirpekar S.M., and Puig M. Effect of flow-stop on noradrenaline release from normal spleens and spleens treated with cocaine, phentolamine or phenoxybenzamine. Br. J. Pharmacol. 43 (1971) 359-369
35. Kiss J.P., Mandl P., and Vizi E.S. Pharmacological evidence for the heterogeneity of nicotinic acetylcholine receptors in the enteric nervous system. FENS Abst. 3 (2006) A044.008
36. Kiss J.P., Windisch K., Balla A., Sershen H., and Lajtha A. Dual effect of DMPP on the resting release of noradrenaline from rat hippocampal slices. Brain Res. Bull. 43 (1997) 257-262
37. Kiss J.P., Windisch K., De Oliveira K., Hennings E.C., Mike A., and Szasz B.K. Differential effect of nicotinic agonists on the [3H]norepinephrine release from rat hippocampal slices. Neurochem. Res. 26 (2001) 943-950
38. Kyle C.J., Petersen H.E., and Overo K.F. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice. Depress. Anxiety 8 (1998) 147-153
39. Langer S.Z. Presynaptic regulation of catecholamine release. Biochem. Pharmacol. 23 (1974) 1793-1800
40. Langer S.Z. The Regulation of Transmitter Release Elicited by Nerve Stimulation Through a Presynaptic Feedback Mechanism (1973), Frontiers in Catecholamine Research Pergamon Press, New York pp. 543-549
41. Lembeck F. Epibatidine: high potency and broad spectrum activity on neuronal and neuromuscular nicotinic acetylcholine receptors. Naunyn Schmiedebergs Arch. Pharmacol. 359 (1999) 378-385
42. Leonard B.E. Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance. Drugs 43 Suppl. 2 (1992) 3-9 discussion: 9-10
43. LePard K.J., and Galligan J.J. Analysis of fast synaptic pathways in myenteric plexus of guinea pig ileum. Am. J. Physiol. 276 (1999) G529-G538
44. Liang S.D., and Vizi E.S. Positive feedback modulation of acetylcholine release from isolated rat superior cervical ganglion. J. Pharmacol. Exp. Ther. 280 (1997) 650-655
45. Lindmar R., Loffelholz K., and Muscholl E. A muscarinic mechanism inhibiting the release of noradrenaline from peripheral adrenergic nerve fibres by nicotinic agents. Br. J. Pharmacol. Chemother. 32 (1968) 280-294
46. Loffelholz K., and Muscholl E. A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Naunyn Schmiedebergs Arch. Pharmakol. 265 (1969) 1-15
47. Lopez-Valdes H., Garcia-Colunga J., and Miledi R. Effects of clomipramine on neuronal nicotinic acetylcholine receptors. Eur. J. Pharmacol. 444 (2002) 13-19
48. Lopez-Valdes H.E., and Garcia-Colunga J. Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake. Mol. Psychiatry 6 (2001) 511-519
49. Mandl P., and Kiss J.P. Inhibitory effect of hemicholinium-3 on presynaptic nicotinic acetylcholine receptors located on the terminal region of myenteric motoneurons. Neurochem. Int. 49 (2006) 327-333
50. Mandl P., Kiss J.P., and Vizi E.S. Functional neurochemical evidence for the presence of presynaptic nicotinic acetylcholine receptors at the terminal region of myenteric motoneurons: a study with epibatidine. Neurochem. Res. 28 (2003) 407-412
51. Mandl P., Vizi E.S., and Kiss J.P. Nonconventional effects of antidepressants in the enteric nervous system. J. Neurochem. 94 S2 (2005) 189
52. Meier R., Beglinger C., Dederding J.P., Meyer-Wyss B., Fumagalli M., Rowedder A., Turberg Y., and Brignoli R. Influence of age, gender, hormonal status and smoking habits on colonic transit time. Neurogastroenterol. Motil. 7 (1995) 235-238
53. Miller D.K., Wong E.H., Chesnut M.D., and Dwoskin L.P. Reboxetine: functional inhibition of monoamine transporters and nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 302 (2002) 687-695
54. Muscettola G., Goodwin F.K., Potter W.Z., Claeys M.M., and Markey S.P. Imipramine and desipramine in plasma and spinal fluid: relationship to clinical response and serotonin metabolism. Arch. Gen. Psychiatry 35 (1978) 621-625
55. Niebler M., and Trendelenburg U. Mechanisms of the release of 3H-noradrenaline by dimethylphenylpiperazinium (DMPP) in the rat vas deferens. Naunyn Schmiedebergs Arch. Pharmacol. 341 (1990) 43-49
56. Ochoa E.L., Chattopadhyay A., and McNamee M.G. Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators. Cell. Mol. Neurobiol. 9 (1989) 141-178
57. Park T.J., Shin S.Y., Suh B.C., Suh E.K., Lee I.S., Kim Y.S., and Kim K.T. Differential inhibition of catecholamine secretion by amitriptyline through blockage of nicotinic receptors, sodium channels, and calcium channels in bovine adrenal chromaffin cells. Synapse 29 (1998) 248-256
58. Parker N.G., and Brown C.S. Citalopram in the treatment of depression. Ann. Pharmacother. 34 (2000) 761-771
59. Pato M.T., Murphy D.L., and DeVane C.L. Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation. J. Clin. Psychopharmacol. 11 (1991) 224-225
60. Paton W.D., and Vizi E.S. The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Br. J. Pharmacol. 35 (1969) 10-28
61. Prado W.A., and Corrado A.P. Cholinergic agonist and antagonist interactions on motor nerve endings of the rat-evidence for the involvement of presynaptic receptors in the regulation of acetylcholine release. Gen. Pharmacol. 18 (1987) 75-81
62. Quick M.W., and Lester R.A. Desensitization of neuronal nicotinic receptors. J. Neurobiol. 53 (2002) 457-478
63. Raiteri M. Presynaptic autoreceptors. J. Neurochem. 78 (2001) 673-675
64. Rana B., McMorn S.O., Reeve H.L., Wyatt C.N., Vaughan P.F., and Peers C. Inhibition of neuronal nicotinic acetylcholine receptors by imipramine and desipramine. Eur. J. Pharmacol. 250 (1993) 247-251
65. Rausch T., Beglinger C., Alam N., Gyr K., and Meier R. Effect of transdermal application of nicotine on colonic transit in healthy nonsmoking volunteers. Neurogastroenterol. Motil. 10 (1998) 263-270
66. Re L. Modulation of acetylcholine release by presynaptic muscarinic autoreceptors. Acta. Physiol. Pharmacol. Ther. Lat. Am. 49 (1999) 215-223
67. Richardson C.E., Morgan J.M., Jasani B., Green J.T., Rhodes J., Williams G.T., Lindstrom J., Wonnacott S., Peel S., and Thomas G.A. Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis. QJM 96 (2003) 57-65
68. Sacaan A.I., Dunlop J.L., and Lloyd G.K. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmacol. Exp. Ther. 274 (1995) 224-230
69. Schneider D.A., Perrone M., and Galligan J.J. Nicotinic acetylcholine receptors at sites of neurotransmitter release to the guinea pig intestinal circular muscle. J. Pharmacol. Exp. Ther. 294 (2000) 363-369
70. Schoepp D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharmacol. Exp. Ther. 299 (2001) 12-20
71. Shytle R.D., Silver A.A., Lukas R.J., Newman M.B., Sheehan D.V., and Sanberg P.R. Nicotinic acetylcholine receptors as targets for antidepressants. Mol. Psychiatry 7 (2002) 525-535
72. Slemmer J.E., Martin B.R., and Damaj M.I. Bupropion is a nicotinic antagonist. J. Pharmacol. Exp. Ther. 295 (2000) 321-327
73. Somogyi G.T., and Szerb J.C. Demonstration of acetylcholine release by measuring efflux of labelled choline from cerebral cortical slices. J. Neurochem. 19 (1972) 2667-2677
74. Starke K. Influence of receptor stimulants on noradrenaline release. Naturwissenschaften 58 (1971) 420
75. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77 (1977) 1-124
76. Starke K., Taube H.D., and Browski E. Presynaptic receptor systems in catacholamingergic transmission. Biochem. Pharmacol. 26 (1977) 259-268
77. Szasz B.K., Mayer A., Zsilla G., Lendvai B., Vizi E.S., and Kiss J.P. Carrier-mediated release of monoamines induced by the nicotinic acetylcholine receptor agonist DMPP. Neuropharmacology 49 (2005) 400-409
78. Tian L., Prior C., Dempster J., and Marshall I.G. Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals. J. Physiol. 476 (1994) 517-529
79. Toide K., and Arima T. Effects of cholinergic drugs on extracellular levels of acetylcholine and choline in rat cortex, hippocampus and striatum studied by brain dialysis. Eur. J. Pharmacol. 173 (1989) 133-141
80. Torocsik A., Oberfrank F., Sershen H., Lajtha A., Nemesy K., and Vizi E.S. Characterization of somatodendritic neuronal nicotinic receptors located on the myenteric plexus. Eur. J. Pharmacol. 202 (1991) 297-302
81. Trindade E., Menon D., Topfer L.A., and Coloma C. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. CMAJ 159 (1998) 1245-1252
82. Vann R.E., James J.R., Rosecrans J.A., and Robinson S.E. Nicotinic receptor inactivation after acute and repeated in vivo nicotine exposures in rats. Brain Res. 1086 (2006) 98-103
83. Vizi E.S. Interaction between adrenergic and cholinergic systems: presynaptic inhibitory effect of noradrenaline on acetylcholine release. J. Neural. Transm. Suppl. 11 (1974) 61-78
84. Vizi E.S. Non-synaptic Interaction Between Neurons: Modulation of Neurochemical Transmission (1984), Wiley, New York
85. Vizi E.S. Presynaptic modulation of neurochemical transmission. Prog. Neurobiol. 12 (1979) 181-290
86. Vizi E.S. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system. Pharmacol. Rev. 52 (2000) 63-89
87. Vizi E.S., and Kiss J.P. Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus 8 (1998) 566-607
88. Vizi E.S., Kiss J.P., and Elenkov I.J. Presynaptic modulation of cholinergic and noradrenergic neurotransmission: interaction between them. News. Physiol. Sci. 6 (1991) 119-123
89. Vizi E.S., and Lendvai B. Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system. Brain Res. Brain Res. Rev. 30 (1999) 219-235
90. Vizi E.S., Sershen H., Balla A., Mike A., Windisch K., Juranyi Z., and Lajtha A. Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nicotinic acetylcholine receptors. Ann. NY Acad. Sci. 757 (1995) 84-99
91. Vizi E.S., and Somogyi G.T. Prejunctional modulation of acetylcholine release from the skeletal neuromuscular junction: link between positive (nicotinic)- and negative (muscarinic)-feedback modulation. Br. J. Pharmacol. 97 (1989) 65-70
92. Vizi E.S., Somogyi G.T., Nagashima H., Duncalf D., Chaudhry I.A., Kobayashi O., Goldiner P.L., and Foldes F.F. Tubocurarine and pancuronium inhibit evoked release of acetylcholine from the mouse hemidiaphragm preparation. Br. J. Anaesth. 59 (1987) 226-231
93. Wang N., Orr-Urtreger A., Chapman J., Rabinowitz R., Nachman R., and Korczyn A.D. Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit. J. Physiol. 542 (2002) 347-354
94. Wessler I. Acetylcholine at motor nerves: storage, release, and presynaptic modulation by autoreceptors and adrenoceptors. Int. Rev. Neurobiol. 34 (1992) 283-384
95. Wessler I., Apel C., Garmsen M., and Klein A. Effects of nicotine receptor agonists on acetylcholine release from the isolated motor nerve, small intestine and trachea of rats and guinea-pigs. Clin. Investig. 70 (1992) 182-189
96. Wessler I., Halank M., Rasbach J., and Kilbinger H. Presynaptic nicotine receptors mediating a positive feed-back on transmitter release from the rat phrenic nerve. Naunyn Schmiedebergs Arch. Pharmacol. 334 (1986) 365-372
97. Wilkie G.I., Hutson P., Sullivan J.P., and Wonnacott S. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochem. Res. 21 (1996) 1141-1148
98. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20 (1997) 92-98
99. Zhou X., Ren J., Brown E., Schneider D., Caraballo-Lopez Y., and Galligan J.J. Pharmacological properties of nicotinic acetylcholine receptors expressed by guinea pig small intestinal myenteric neurons. J. Pharmacol. Exp. Ther. 302 (2002) 889-897